Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Autosomal dominant tubulointerstitial kidney disease-UMOD is the most frequent non polycystic genetic kidney disease.

Gast C, Marinaki A, Arenas-Hernandez M, Campbell S, Seaby EG, Pengelly RJ, Gale DP, Connor TM, Bunyan DJ, Hodaňová K, Živná M, Kmoch S, Ennis S, Venkat-Raman G.

BMC Nephrol. 2018 Oct 30;19(1):301. doi: 10.1186/s12882-018-1107-y.

2.

Mutations in mitochondrial DNA causing tubulointerstitial kidney disease.

Connor TM, Hoer S, Mallett A, Gale DP, Gomez-Duran A, Posse V, Antrobus R, Moreno P, Sciacovelli M, Frezza C, Duff J, Sheerin NS, Sayer JA, Ashcroft M, Wiesener MS, Hudson G, Gustafsson CM, Chinnery PF, Maxwell PH.

PLoS Genet. 2017 Mar 7;13(3):e1006620. doi: 10.1371/journal.pgen.1006620. eCollection 2017 Mar.

3.

A novel COL4A1 frameshift mutation in familial kidney disease: the importance of the C-terminal NC1 domain of type IV collagen.

Gale DP, Oygar DD, Lin F, Oygar PD, Khan N, Connor TM, Lapsley M, Maxwell PH, Neild GH.

Nephrol Dial Transplant. 2016 Nov;31(11):1908-1914. Epub 2016 Apr 8.

4.

The natural history of immunoglobulin M nephropathy in adults.

Connor TM, Aiello V, Griffith M, Cairns T, Roufosse CA, Cook HT, Pusey CD.

Nephrol Dial Transplant. 2017 May 1;32(5):823-829. doi: 10.1093/ndt/gfw063.

5.

Combinatorial Conflicting Homozygosity (CCH) analysis enables the rapid identification of shared genomic regions in the presence of multiple phenocopies.

Levine AP, Connor TM, Oygar DD, Neild GH, Segal AW, Maxwell PH, Gale DP.

BMC Genomics. 2015 Mar 10;16:163. doi: 10.1186/s12864-015-1360-4.

6.

Genetic testing can resolve diagnostic confusion in Alport syndrome.

Adam J, Connor TM, Wood K, Lewis D, Naik R, Gale DP, Sayer JA.

Clin Kidney J. 2014 Apr;7(2):197-200. Epub 2013 Dec 18.

7.

Incidence of end-stage renal disease in the Turkish-Cypriot population of Northern Cyprus: a population based study.

Connor TM, Oygar DD, Gale DP, Steenkamp R, Nitsch D, Neild GH, Maxwell PH.

PLoS One. 2013;8(1):e54394. doi: 10.1371/journal.pone.0054394. Epub 2013 Jan 17.

8.

Absorbable laparoscopic cigarette sponge.

Brandli DW, Bernie JE, Connor TM, Sundaram CP.

JSLS. 2005 Jul-Sep;9(3):362-3.

9.

Involvement of the central nucleus of the amygdala and nucleus accumbens core in mediating Pavlovian influences on instrumental behaviour.

Hall J, Parkinson JA, Connor TM, Dickinson A, Everitt BJ.

Eur J Neurosci. 2001 May;13(10):1984-92.

PMID:
11403692
10.

bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis.

McCurrach ME, Connor TM, Knudson CM, Korsmeyer SJ, Lowe SW.

Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2345-9.

11.

p53 modulation of anchorage independent growth and experimental metastasis.

Nikiforov MA, Hagen K, Ossovskaya VS, Connor TM, Lowe SW, Deichman GI, Gudkov AV.

Oncogene. 1996 Oct 17;13(8):1709-19.

PMID:
8895517
12.
13.

Hypertrophic cardiomyopathy and complete heart block in infancy.

Maron BJ, Connor TM, Roberts WC.

Am Heart J. 1981 Jun;101(6):857-60. No abstract available.

PMID:
7195145
14.

L-5-Hydroxytryptophan-induced drinking in rats: possible mechanisms for induction.

Threatte RM, Fregly MJ, Connor TM, Kikta DC.

Pharmacol Biochem Behav. 1981 Mar;14(3):385-91.

PMID:
7015366
15.

Dipsogenic effect of L-5-hydroxytryptophan in rats.

Fregly MJ, Connor TM, Kikta DC, Threatte RM.

Brain Res Bull. 1980 Nov-Dec;5(6):719-24.

PMID:
6970610
17.

Congenital mesoblastic nephroma.

King DR, Buck D, Kleinman PB, Connor TM.

Am J Dis Child. 1978 Nov;132(11):1139-40. No abstract available.

PMID:
213965

Supplemental Content

Loading ...
Support Center